• University of California, San Francisco
    $120,000 through June, 2020

    to develop an innovative neuroimaging method that will detect oxidative stress in patients with MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Regents of the University of California, Irvine
    $120,000 through December, 2020

    to study whether lower GlcNAc levels promote the progression of MS by preventing oligodendrocyte formation and reducing remyelination.

    Multiple Sclerosis USA Awarded: May, 2017
  • New York Stem Cell Foundation, Inc.
    $120,000 through December, 2019

    to study the properties of oligodendrocyte progenitor cells in MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Case Western Reserve University
    $120,000 through June, 2018

    to study the unifying mechanisms all remyelinating molecules have in common and to share findings with the field of MS research.

    Multiple Sclerosis USA Awarded: May, 2017
  • University of California, San Francisco
    $120,000 through June, 2019

    to study misfolded tau aggregates found in the brains of MS patients.

    Multiple Sclerosis USA Awarded: May, 2017
  • Regents of the University of Colorado
    $120,000 through June, 2019

    to study mechanisms regulating MS-related myelin injury and repair in cortical lesions.

    Multiple Sclerosis USA Awarded: May, 2017
  • University of Southern California
    $120,000 through December, 2019

    to study the potential of angiotensin 1-7 to promote oligodendrocyte progenitor cell remyelination.

    Multiple Sclerosis USA Awarded: May, 2017
  • Johns Hopkins University
    $45,938 through June, 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Vanderbilt University Medical Center
    $120,000 through June, 2020

    to apply advanced imaging to the study of the cervical spinal cord in patients with MS.

    Multiple Sclerosis USA Awarded: May, 2017
  • Baylor College of Medicine
    $120,000 through June, 2019

    to study how targeting the Wnt receptor complex may increase myelin repair in MS patients.

    Multiple Sclerosis USA Awarded: May, 2017